Trial to Assess the Efficacy and Safety of Nafamostat Mesilate During Continuous Renal Replacement Therapy
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
Randomized study to evaluate the efficacy and safety of nafamostat mesilate use during
continuous renal replacement therapy in acute kidney injury patients at a high risk of
bleeding.
Phase:
Phase 4
Details
Lead Sponsor:
Kyungpook National University Kyungpook National University Hospital